| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.295 | 5.771 | 9.395 | 19.473 | 28.736 | 36.419 |
| Total Income - EUR | - | - | - | - | 2.295 | 5.771 | 9.395 | 19.563 | 28.736 | 36.441 |
| Total Expenses - EUR | - | - | - | - | 44 | 5.490 | 5.720 | 5.355 | 13.572 | 12.435 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.250 | 281 | 3.674 | 14.208 | 15.164 | 24.006 |
| Net Profit/Loss - EUR | - | - | - | - | 2.181 | 122 | 3.398 | 13.695 | 12.582 | 19.780 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Somnoclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 24 | 15 | 0 | 0 | 755 | 359 |
| Current Assets | - | - | - | - | 2.301 | 2.415 | 6.683 | 15.330 | 13.006 | 32.404 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 21 | 0 |
| Receivables | - | - | - | - | 0 | 241 | 6.087 | 12.846 | 1.642 | 21.953 |
| Cash | - | - | - | - | 2.301 | 2.173 | 597 | 2.484 | 11.343 | 10.452 |
| Shareholders Funds | - | - | - | - | 2.224 | 1.842 | 3.328 | 13.744 | 12.631 | 19.829 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 101 | 588 | 3.356 | 1.587 | 1.275 | 13.040 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Somnoclinic S.r.l.